Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Generation of chimeric antigen receptor T cells targeting p95HER2 in solid tumors.
Román Alonso M, Grinyó-Escuer A, Duro-Sánchez S, Rius-Ruiz I, Bort-Brusca M, Escorihuela M, Maqueda-Marcos S, Pérez-Ramos S, Gago J, Nogales V, Espinosa-Bravo M, Peg V, Escrivá-de-Romaní S, Foradada L, Soucek L, Braña I, Galvao V, Martín-Lluesma S, Moessner E, Klein C, Garralda E, Saura C, Arribas J. Román Alonso M, et al. Among authors: duro sanchez s. Nat Commun. 2024 Nov 18;15(1):9589. doi: 10.1038/s41467-024-53265-7. Nat Commun. 2024. PMID: 39557820 Free PMC article.
ERK1/2 mitogen-activated protein kinase dimerization is essential for the regulation of cell motility.
de la Fuente-Vivas D, Cappitelli V, García-Gómez R, Valero-Díaz S, Amato C, Rodriguéz J, Duro-Sánchez S, von Kriegsheim A, Grusch M, Lozano J, Arribas J, Casar B, Crespo P. de la Fuente-Vivas D, et al. Among authors: duro sanchez s. Mol Oncol. 2024 Sep 12. doi: 10.1002/1878-0261.13732. Online ahead of print. Mol Oncol. 2024. PMID: 39263917 Free article.
Immunotherapies against HER2-Positive Breast Cancer.
Duro-Sánchez S, Alonso MR, Arribas J. Duro-Sánchez S, et al. Cancers (Basel). 2023 Feb 8;15(4):1069. doi: 10.3390/cancers15041069. Cancers (Basel). 2023. PMID: 36831412 Free PMC article. Review.
Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II-Induced Hypertension.
Díaz Del Campo LS, García-Redondo AB, Rodríguez C, Zaragoza C, Duro-Sánchez S, Palmas F, de Benito-Bueno A, Socuéllamos PG, Peraza DA, Rodrigues-Díez R, Valenzuela C, Dalli J, Salaices M, Briones AM. Díaz Del Campo LS, et al. Among authors: duro sanchez s. Hypertension. 2023 Jan;80(1):84-96. doi: 10.1161/HYPERTENSIONAHA.122.19448. Epub 2022 Nov 7. Hypertension. 2023. PMID: 36337053 Free article.
Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody-Drug Conjugates in Breast Cancer.
Duro-Sánchez S, Nadal-Serrano M, Lalinde-Gutiérrez M, Arenas EJ, Bernadó Morales C, Morancho B, Escorihuela M, Pérez-Ramos S, Escrivá-de-Romaní S, Gandullo-Sánchez L, Pandiella A, Esteve-Codina A, Rodilla V, Dijcks FA, Dokter WHA, Cortés J, Saura C, Arribas J. Duro-Sánchez S, et al. Cancer Res. 2022 Dec 16;82(24):4670-4679. doi: 10.1158/0008-5472.CAN-22-0787. Cancer Res. 2022. PMID: 36222720 Free PMC article.